Ataraxis AI

Clinical AI for Predictive Cancer Care

Ataraxis AI is a pioneering artificial intelligence platform designed to make disease predictable by empowering physicians with advanced multi-modal tools that improve treatment selection and patient outcomes. The company specializes in precision medicine for oncology, particularly breast cancer, using cutting-edge AI methods to analyze diverse patient data and deliver clinically actionable insights.

Core Technology & Capabilities

Ataraxis develops proprietary AI foundation models—including Falcon, trained on hundreds of millions of pan-cancer pathology slide images—that extract novel clinical, morphological, and molecular features from multi-modal patient data. Their technology:

• Assesses disease aggressiveness and predicts risk of cancer recurrence or death
• Predicts how various treatment options benefit different patients
• Delivers results within 24 hours from data receipt (same-day turnaround)
• Preserves physical tissue samples, requiring no additional histology preparation
• Discovers novel features that capture cancer heterogeneity beyond single data types

Ataraxis Breast: AI-Native Clinical Platform

The flagship product, Ataraxis Breast, offers clinically validated prognostic and predictive tools specifically for breast cancer management:

• Recurrence Risk Assessment: Evaluate likelihood of cancer returning
• Chemotherapy Benefit Prediction: Determine which patients benefit from chemotherapy
• Neoadjuvant Response Prediction: Forecast response to pre-surgery therapy (Ataraxis Breast NEO)

Who It's For

Ataraxis serves oncologists, pathologists, and cancer care teams at leading international cancer centers and health systems. The platform supports clinical decision-making by providing precise, personalized predictions that complement traditional diagnostic methods. With $20.4 million in Series A funding, Ataraxis is accelerating clinical deployment across healthcare institutions.

Research Foundation

The company's work spans advanced AI research domains including causality, representation learning, and survival analysis, ensuring their models remain at the forefront of AI precision medicine. Their generalizable foundation models enable rapid deployment of new tests and continuous improvement in predictive accuracy.